Pharmaceutical Industry Information Portal

HomeTagsCOVID-19

All posts by tag

COVID-19

Binnopharm Group’s revenue for 9M 2021 surges by 22.1% to over RUB 18 bn

Binnopharm Group, one of the largest medicine manufacturers in Russia and part of Sistema Group, announces Q3 and 9M 2021 IFRS financial results. Q3 and...

Efficacy of Areplivir (favipiravir) in the treatment of COVID-19 discussed at the 16th Russian Congress of Internal Medicine

On the first day of the 16th Russian Congress of Internal Medicine, Promomed Group organized a satellite symposium «Always on the same side against...

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

Russian Health Ministry recommends RA drug olokizumab for patients with COVID-19 of any severity

The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...

Remdeform is included into all COVID-19 treatment regimens

Remdesivir (trade name: Remdeform, MA No. ЛП-006505 of October 14, 2020г) has been included into all in-hospital treatment regimens in the 12th version of...

Areplivir developed by Promomed for the treatment of coronavirus infection received marketing authorization in Uzbekistan

Areplivir, included in the guidelines of the Ministry of Health of Russia for the treatment of COVID-19, received marketing authorization in Uzbekistan. On August 4,...
spot_img

Expert Articles

spot_img